Telomere dysfunction: multiple paths to the same end

被引:53
作者
Harrington, L
Robinson, MO
机构
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Amgen Res Inst, Toronto, ON M5G 2C1, Canada
关键词
telomere; telomerase; genome stability; DNA damage; apoptosis; p53;
D O I
10.1038/sj.onc.1205084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular cloning of telomerase and telomere components has enabled the analysis and precise manipulation of processes that regulate telomere length maintenance. In mammalian cells and in other organisms, we now recognize that disruption of telomere integrity via any one of a number of perturbations induces chromosome instability and the activation of DNA damage responses. Thus, telomere dysfunction may represent a physiological trigger of the DNA damage or apoptotic response in an analogous fashion to other genotoxic insults that introduce chromosome breaks. Initial studies in mice lacking the murine telomerase RNA and in cells expressing a dominant negative version of the telomere binding protein TRF2 revealed a strong p53-dependent response to telomere dysfunction. Yet, telomere dysfunction exhibits p53-independent effects as well, an observation supported by p53-independent responses to telomere dysfunction in p53 mutant human tumor cell lines and mouse cells. As most tumors are compromised for p53 function, examination of this p53-independent response warrants closer attention. A better understanding of this p53-independent response may prove critical for determining the ultimate utility of telomerase inhibitors in the clinic. This review will summarize our current understanding of the molecular responses to telomere dysfunction in mammalian cells.
引用
收藏
页码:592 / 597
页数:6
相关论文
共 49 条
[31]   A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation [J].
Kim, MM ;
Rivera, MA ;
Botchkina, IL ;
Shalaby, R ;
Thor, AD ;
Blackburn, EH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7982-7987
[32]   Essential role of mouse telomerase in highly proliferative organs [J].
Lee, HW ;
Blasco, MA ;
Gottlieb, GJ ;
Horner, JW ;
Greider, CW ;
DePinho, RA .
NATURE, 1998, 392 (6676) :569-574
[33]   Telomere dysfunction alters the chemotherapeutic profile of transformed cells [J].
Lee, KH ;
Rudolph, KL ;
Ju, YJ ;
Greenberg, RA ;
Cannizzaro, L ;
Chin, L ;
Weiler, SR ;
DePinho, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3381-3386
[34]   Reverse transcriptase motifs in the catalytic subunit of telomerase [J].
Lingner, J ;
Hughes, TR ;
Shevchenko, A ;
Mann, M ;
Lundblad, V ;
Cech, TR .
SCIENCE, 1997, 276 (5312) :561-567
[35]  
Ludwig A, 2001, CANCER RES, V61, P3053
[36]   Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability [J].
Marusic, L ;
Anton, M ;
Tidy, A ;
Wang, P ;
Villeponteau, B ;
Bacchetti, S .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6394-6401
[37]   Absence of cancer-associated changes in human fibroblasts immortalized with telomerase [J].
Morales, CP ;
Holt, SE ;
Ouellette, M ;
Kaur, KJ ;
Yan, Y ;
Wilson, KS ;
White, MA ;
Wright, WE ;
Shay, JW .
NATURE GENETICS, 1999, 21 (01) :115-118
[38]   Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas [J].
Nakayama, JI ;
Tahara, H ;
Tahara, E ;
Saito, M ;
Ito, K ;
Nakamura, H ;
Nakanishi, T ;
Tahara, E ;
Ide, T ;
Ishikawa, F .
NATURE GENETICS, 1998, 18 (01) :65-68
[39]   Longevity, stress response, and cancer in aging telomerase-deficient mice [J].
Rudolph, KL ;
Chang, S ;
Lee, HW ;
Blasco, M ;
Gottlieb, GJ ;
Greider, C ;
DePinho, RA .
CELL, 1999, 96 (05) :701-712
[40]   Telomere dysfunction and evolution of intestinal carcinoma in mice and humans [J].
Rudolph, KL ;
Millard, M ;
Bosenberg, MW ;
DePinho, RA .
NATURE GENETICS, 2001, 28 (02) :155-159